BEGIN:VCALENDAR
PRODID:-//planitpurple.northwestern.edu//iCalendar Event//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:America/Chicago
TZURL:http://tzurl.org/zoneinfo-outlook/America/Chicago
X-LIC-LOCATION:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SEQUENCE:0
DTSTART;TZID=America/Chicago:20260611T140000
DTEND;TZID=America/Chicago:20260611T150000
DTSTAMP:20260425T160715Z
SUMMARY:CAN Seminar Series: Precision psychiatry in bipolar disorder: From neuronal hyperexcitability and lithium response mechanisms to biomarkers and targeted therapeutics.
UID:641952@northwestern.edu
TZID:America/Chicago
DESCRIPTION:Guy A. Rouleau\,  Professor\, Department of Neurology & Neurosurgery\, McGill University    The first part of the presentation will focus on the investigation into the mechanisms underlying the neuronal hyperexcitability phenotype observed in iPSC-derived neurons from patients with bipolar disorder (BD). This segment will reveal the selective effects of lithium through the Akt and AMPK pathways and will propose innovative therapeutic strategies tailored for both lithium-responsive and non-responsive patients. The second part will address the translational potential of these cellular phenotypes by exploring extracellular vesicles (EVs) as a source of clinically accessible biomarkers. We will present evidence that EVs derived from patient neurons carry distinct protein and miRNA signatures associated with BD and lithium responsiveness. Functional assays further indicate that BD-derived secreted factors can modulate neuronal network activity\, supporting a mechanistic link between EV cargo and disease-relevant phenotypes.  Finally\, the presentation will introduce recent efforts to move beyond lithium by identifying more selective therapeutic strategies targeting the hyperexcitability phenotype. By combining cell surface proteomics\, synaptic fractionation\, electrophysiology\, and calcium imaging\, we are identifying ion channels and synaptic proteins that drive early network hyperexcitability in BD neurons. We then test whether pharmacological targeting of these candidates can normalize neuronal activity\, providing a rational framework for the development of more specific and potentially better-tolerated treatments.  Together\, this work illustrates a translational pipeline from patient-derived cellular models to biomarker development and mechanism-based therapeutics\, advancing a precision medicine approach to bipolar disorder.  Author List: Anouar Khayachi\, Malak Abuzgaya\, Alessia Pietrantonio\, Yumin Liu\, Austen Milnerwood\, Martin Alda\, Guy Rouleau\n\nWebcast Link: https://northwestern.zoom.us/j/95605834128
LOCATION:Ward Building\, 5-230\, 303 E. Chicago Avenue\, Chicago\, IL 60611
TRANSP:OPAQUE
URL:https://planitpurple.northwestern.edu/event/641952
CREATED:20260424T050000Z
STATUS:CONFIRMED
LAST-MODIFIED:20260424T050000Z
PRIORITY:0
BEGIN:VALARM
TRIGGER:-PT10M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR